Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors

被引:96
|
作者
Sunderkoetter, C. [1 ]
Herrgott, I. [1 ]
Brueckner, C. [2 ]
Moinzadeh, P. [3 ]
Pfeiffer, C. [4 ]
Gerss, J. [5 ]
Hunzelmann, N. [3 ]
Boehm, M. [1 ]
Krieg, T. [3 ]
Mueller-Ladner, U. [6 ]
Genth, E. [7 ]
Schulze-Lohoff, E. [8 ]
Meurer, M. [4 ]
Melchers, I. [9 ]
Riemekasten, G. [2 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[4] Dresden Univ Hosp, Dept Dermatol, Dresden, Germany
[5] Univ Munster, Coordinating Ctr Clin Trials, Dept Med Informat & Biomath, D-48149 Munster, Germany
[6] Univ Giessen, Kerckhoff Clin, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[7] Univ Aachen, D-5100 Aachen, Germany
[8] Hosp Cologne Merheim, Med Clin 1, Cologne, Germany
[9] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany
关键词
digital ulcers; German Network; Raynaud's phenomenon; risk factors; systemic sclerosis; RAYNAUDS-PHENOMENON; GERMAN NETWORK; SCLERODERMA TRIALS; ILOPROST TREATMENT; DISEASE; PATHOPHYSIOLOGY; CONSEQUENCES; DERMATOLOGY; MULTICENTER; MANAGEMENT;
D O I
10.1111/j.1365-2133.2008.09004.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e. g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. Objectives To identify potential risk factors for DU in patients with SSc. Methods We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). Results Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti-Scl70 antibodies, young age at onset of Raynaud's phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients' probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR > 30 mm h(-1), anti-Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2-3 years earlier than patients without DU. Conclusions The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 50 条
  • [1] Detection of possible risk factors for digital ulcers in systemic sclerosis
    Herrgott, Ilka
    Sunderkoetter, Cord
    Riemekasten, Gabriela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (03) : S84 - S84
  • [2] Detection of possible risk factors for digital ulcers in Systemic Sclerosis
    Herrgott, I
    Gerss, J.
    Sunderkoetter, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 197 - 197
  • [3] POSSIBLE RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
    Herrgott, I.
    Gerss, J.
    Sunderkoetter, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S179 - S179
  • [4] Differences in the activity of systemic sclerosis with patients with and without digital ulcers
    Cvijovic, A.
    Brankovic, M.
    Damjanov, N.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 218 - 218
  • [5] Digital ulcers in patients with systemic sclerosis
    Chung, L
    Fiorentino, D
    AUTOIMMUNITY REVIEWS, 2006, 5 (02) : 125 - 128
  • [6] FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
    Stevens, W.
    Nikpour, M.
    Byron, J.
    Roddy, J.
    Sahhar, J.
    Zochling, J.
    Nash, P.
    Youssef, P.
    Kathleen, T.
    Sturgess, A.
    Hill, C.
    Major, G.
    Leslie, S.
    Proudman, S.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 13 - 13
  • [7] Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis
    Miura, Shunsuke
    Asano, Yoshihide
    Saigusa, Ryosuke
    Yamashita, Takashi
    Taniguchi, Takashi
    Takahashi, Takehiro
    Ichimura, Yohei
    Toyama, Tetsuo
    Tamaki, Zenshiro
    Tada, Yayoi
    Sugaya, Makoto
    Sato, Shinichi
    Kadono, Takafumi
    JOURNAL OF DERMATOLOGY, 2015, 42 (05): : 528 - 531
  • [8] Bosentan for digital ulcers in patients with systemic sclerosis
    Nagai, Yayoi
    Hasegawa, Michiko
    Hattori, Tomoyasu
    Okada, Etsuko
    Tago, Osamu
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2012, 39 (01): : 48 - 51
  • [9] Pathophysiology of digital ulcers in patients with systemic sclerosis
    Giuggioli, D.
    Colaci, M.
    Manfredi, A.
    Sebastiani, M.
    Ferri, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 73 - 73
  • [10] Management of digital ulcers in patients with systemic sclerosis
    Riemekasten, G.
    Hoffmann, U.
    Sunderkoetter, C.
    Weiss, N.
    Kuhn, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (1-2) : 34 - 40